ABSTRACT
Cost and cost-effectiveness analysis are health economic tools that measure costs of a health condition and the monetized health benefits associated with an intervention relative to its implementation cost. This type of analysis does not explicitly take a sectorial or societal perspective where the costs and effectiveness of all possible interventions are compared in order to select the mix that maximizes health benefits for the population as a whole with a given set of resource constraints. The estimated cost-effectiveness of a single proposed new intervention is compared either with the cost effectiveness of a set of existing interventions reported in the literature or with a fixed price cut-off point representing the assumed social willingness to pay for an additional unit of health. A cost-effectiveness study using a decision analysis model assessed a screening strategy for early preeclampsia relative to no screening in Israel.
